Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Main Illumina 450k DNAm datasets used. We list the main datasets used in this study, the cell-types/tissue profiled, whether the data was used for reference database construction (if yes, we specify which cell-types were used), whether the data was used for validation/evaluation purposes (if yes, we specify which cell-types were used) and the reference/citation
Dataset Name | Tissue/cell-types | Use in Reference DNAm Database | Testing/Evaluation | Reference |
---|---|---|---|---|
Reinius et al. | WB, PBMC, NK, B, CD4T, CD8T, Monoc, Neutro, Eosino. (n = 6 of each) | NK, B, CD4T, CD8T, Monoc., Neutro., Eosino. | WB & PBMC | [24 (link)] |
Liu et al. | WB (n = 335 controls, n = 354 rheumathoid arthritis cases) | No | Average Flow Cytometry estimates for cases and controls | [2 (link)] |
Koestler et al. | WB (n = 18) | No | 12 Reconstructed WB mixtures + 6 WB samples with Flow Cytometry estimates | [20 (link)] |
Zilbauer et al. | PBMC, CD4T, CD8T, NK, B, Monoc, Neutro. (n = 6 of each) | No | In-silico mixtures of purified blood cell subtypes | [27 (link)] |
ENCODE | Various | HMEC, HRCE, IMR90, Liver | No | [22 (link)] |
Slieker et al. | Various | Pancreas | Liver | [26 (link)] |
SCM2 | Various | No | HRCE, Pancreas, IMR90 | [29 (link)] |
Lowe et al. | Various | No | HMEC | [28 (link), 35 (link)] |
Teschendorff et al. | WB (n = 152) | No | Smoking associated DMCs | [31 (link)] |
Abbreviations: DNAm = DNA methylation, WB = whole blood, PBMC = peripheral blood mononuclear cells, HMEC = human mammary epithelial cells, HRCE = human renal cortical epithelia, IMR90 (fetal lung fibroblast), SCM2 = Stem-Cell-Matrix Compendium-2, DMCs = differentially methylated CpGs, NK = natural killer cells, B = B-cell, Monoc = Monocytes, Neutro. = Neutrophils, Eosino = Eosinophils, CD4T = CD4+ T-cells, CD8T = CD8+ T-cells
Example 70
Heat lauric acid, stearic acid, myristic acid, oleic acid, squalene oil, rosehip oil, lemongrass oil, olive oil, and/or jojoba oil to about 75° C. Then dissolve NaOH in water (or an initial aliquot of water) and heat the solution to about 70° C. To the NaOH solution add glycerin and silk, then add the blend of lauric acid, stearic acid, myristic acid, oleic acid, squalene oil, rosehip oil, lemongrass oil, olive oil, and/or jojoba oil. Allow the mixture to cool. Where applicable, reheat the mixture and add rosehip oil, squalene oil, and/or 2M HCl. Then, where applicable, add an ending aliquot of water and/or olive oil. Finally, add aspen bark and/or sodium anisate to yield the combination cleanser.
Example 96
In an embodiment, an exemplary foot balm formulation that may provide a footbalm product may include:
Example 61
Dissolve hyaluronic acid in water to prepare a solution and then add silk slowly. Refrigerate the solution. Heat a combination of lauric acid, jojoba oil, myristic acid, and/or stearic acid to about 75° C. Then, heat the hyaluronic acid/silk solution to about 55° C. Add the acid/jojoba oil combination to the hyaluronic acid/silk solution and mix. Allow the solution to cool and then add aspen bark and sodium anisate to provide the cleanser.
Example 95
In an embodiment, a foot balm formulation that may provide a foot balm product may include: